Orientia tsutsugamushi, a cause of scrub typhus is emerging as an important pathogen in several parts of the tropics. The control of this infection relies on rapid diagnosis, specific treatment, and prevention through vector control. Development of a vaccine for human use would be very important as a public health measure. Antibody and T‐cell response have been found to be important in the protection against scrub typhus. This study was undertaken to predict the peptide vaccine that elicits both B‐ and T‐cell immunity. The outer‐membrane protein, 47‐kDa high‐temperature requirement A was used as the target protein for the identification of protective antigen(s). Using BepiPred2 program, the potential B‐cell epitope PNSSWGRYGLKMGLR with high conservation among
O. tsutsugamushi and the maximum surface exposed residues was identified. Using IEDB, NetMHCpan, and NetCTL programs, T‐cell epitopes MLNELTPEL and VTNGIISSK were identified. These peptides were found to have promiscuous class‐I major histocompatibility complex (MHC) binding affinity to MHC supertypes and high proteasomal cleavage, transporter associated with antigen processing prediction, and antigenicity scores. In the I‐TASSER generated model, the C‐score was −0.69 and the estimated TM‐score was 0.63 ± 0.14. The location of the epitope in the 3D model was external. Therefore, an antibody to this outer‐membrane protein epitope could opsonize the bacterium for clearance by the reticuloendothelial system. The T‐cell epitopes would generate T‐helper function. The B‐cell epitope(s) identified could be evaluated as antigen(s) in immunodiagnostic assays. This cocktail of three peptides would elicit both B‐ and T‐cell immune response with a suitable adjuvant and serve as a vaccine candidate.